SCHEMBL1336408

SCHEMBL1336408

CCOC(Cc1ccc(OCCn2cccc2C(=O)c2ccccc2)cc1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 18/20 0.62
PPARA Q07869 18/20 0.62
PPARD Q03181 8/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6076323 0.92 PPARG (0.52) PPARGPPARAPPARD
SCHEMBL543487 0.89 PPARA (0.62) PPARGPPARAPPARD
SCHEMBL542924 0.85 PPARA (0.63) PPARGPPARAPPARD
SCHEMBL1338568 0.84 PPARG (0.64) PPARGPPARAPPARD
Ethane SCHEMBL1834451 0.83 PPARA (0.63) PPARGPPARAPPARD
SCHEMBL543177 0.82 PPARA (0.62) PPARGPPARAPPARD
SCHEMBL5390766 0.82 PPARA (0.78) PPARGPPARAPPARD
SCHEMBL5385354 0.82 PPARA (0.78) PPARGPPARAPPARD
SCHEMBL543819 0.82 PPARA (0.63) PPARGPPARAPPARD
SCHEMBL543301 0.80 PPARA (0.51) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8212057-B2 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILA HEALTHCARE LIMITED (IN) 2012-07-03 US claimed
US-20110275669-A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILLA HEALTHCARE LIMITED (IN) 2011-11-10 US claimed
US-20070238776-A1 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine CADILLA HEALTHCARE LIMITED (IN) 2007-10-11 US claimed
US-20030236254-A1 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILA HEALTHCARE LIMITED (IN) 2003-12-25 US claimed
US-8558009-B2 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILA HEALTHCARE LIMITED (IN) 2013-10-15 US disclosed
US-8212057-B2 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILA HEALTHCARE LIMITED (IN) 2012-07-03 US disclosed
US-20110275669-A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILLA HEALTHCARE LIMITED (IN) 2011-11-10 US disclosed
US-20070238776-A1 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine CADILLA HEALTHCARE LIMITED (IN) 2007-10-11 US disclosed
US-7041837-B2 Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILLA HEALTHCARE LIMITED (IN) 2006-05-09 US disclosed
US-20030236254-A1 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine CADILA HEALTHCARE LIMITED (IN) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275669-A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine CETP, LIPA, LIPC PPARG 497/4885PPARA 263/4885PPARD 312/4885
US-20070238776-A1 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine LIPC, CETP, PNLIP PPARG 217/4885PPARA 126/4885PPARD 133/4885
US-20030236254-A1 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine LIPA, LIPC, CYP46A1 PPARG 129/4885PPARA 68/4885PPARD 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.